Cash transfer during the COVID-19 pandemic: a multicentre, randomised controlled trial.

Persaud, Navindra; Thorpe, Kevin E; Bedard, Michael; Hwang, Stephen W; Pinto, Andrew; Jüni, Peter; Da Costa, Bruno R. (2021). Cash transfer during the COVID-19 pandemic: a multicentre, randomised controlled trial. Family medicine and community health, 9(4), e001452. BMJ Publishing Group 10.1136/fmch-2021-001452

Preview

Text Persaud_FamMedCommunityHealth_2021.pdf - Published Version Available under License Creative Commons: Attribution-Noncommercial (CC-BY-NC). Download (286kB) | Preview

OBJECTIVE

To evaluate the effect of a one-time cash transfer of $C1000 in people who are unable to physically distance due to insufficient income.

DESIGN

Open-label, multi-centre, randomised superiority trial.

SETTING

Seven primary care sites in Ontario, Canada; six urban sites associated with St. Michael's Hospital in Toronto and one in Manitoulin Island.

PARTICIPANTS

392 individuals who reported trouble affording basic necessities due to disruptions related to COVID-19.

INTERVENTION

After random allocation, participants either received the cash transfer of $C1000 (n=196) or physical distancing guidelines alone (n=196).

MAIN OUTCOME MEASURES

The primary outcome was the maximum number of symptoms consistent with COVID-19 over 14 days. Secondary outcomes were meeting clinical criteria for COVID-19, SARS-CoV-2 presence, number of close contacts, general health and ability to afford basic necessities.

RESULTS

The primary outcome of number of symptoms reported by participants did not differ between groups after 2 weeks (cash transfer, mean 1.6 vs 1.9, ratio of means 0.83; 95% CI 0.56 to 1.24). There were no statistically significant effects on secondary outcomes of the meeting COVID-19 clinical criteria (7.9% vs 12.8%; risk difference -0.05; 95% CI -0.11 to 0.01), SARS-CoV-2 presence (0.5% vs 0.6%; risk difference 0.00 95% CI -0.02 to 0.02), mean number of close contacts (3.5 vs 3.7; rate ratio 1.10; 95% CI 0.83 to 1.46), general health very good or excellent (60% vs 63%; risk difference -0.03 95% CI -0.14 to 0.08) and ability to make ends meet (52% vs 51%; risk difference 0.01 95% CI -0.10 to 0.12).

CONCLUSIONS

A single cash transfer did not reduce the COVID-19 symptoms or improve the ability to afford necessities. Further studies are needed to determine whether some groups may benefit from financial supports and to determine if a higher level of support is beneficial.

TRIAL REGISTRATION NUMBER

NCT04359264.

Interest & Impact

Downloads

92 since deposited on 06 Jan 2022
39 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item